Keywords = Disease activity
Systemic Lupus Erythematosus in Egyptian Males: A Study of Clinical Features, Serology, Outcome, and Review of Literature

Volume 89, December, December 2021, Pages 3063-3073

NORA YOUSRY ELSAID, M.D.; MARWA NIAZY, M.D.; FATEMA TALAAT ELGENGEHY, M.D.; SALLY S. MOHAMED, M.Sc.


High-Mobility Group Box 1 Protein (HMGBl): Role in Lupus Nephritis

Volume 88, December, December 2020, Pages 2421-2429

MERVAT ABO GABAL, M.D.; HANAN FAROUK, M.D.; NORAN O. EL AZIZI, M.D.; MARYAM A. ABDULRAHMAN, M.D.; DALIA GAMAL, M.Sc.; NEAMA M. LOTFY, M.D.


CD5+ B Lymphocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity

Volume 88, September, September 2020, Pages 1629-1640

NAHED M. SHERIF, M.D.; AHMED M. ELYASAKI, M.D.; SOHA E. IBRAHIM, M.D.; HADEEL TAHA ALI MAHDI, M.Sc.


CD5+ B Lymphocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity

Volume 88, June, June 2020, Pages 1055-1063

NAHED MONIR SHERIF, M.D.; AHMED M. ELYASAKI, M.D.;; SOHA E. IBRAHIM, M.D.; HADEEL T. ALI MAHDI, M.Sc.


The Role of Soluble Subtype of the Receptor for Advanced Glycation End Product (sRAGE) in Rheumatoid Arthrirtis Disease Activity and Treatment Follow-up

Volume 87, June, June 2019, Pages 1857-1862

DOAA M.A. EL-ZOGHBY, M.D.; NEHAL EL-FAWY MAHMOUD, M.D.; NERMIN H. EL-GHARBAWY, M.D.; SAFAA M. ABD EL-RAHMAN, M.D.